Company
Candel Therapeutics, Inc.
CADL · CIK 0001841387
Sale of 59,379 shares at $10.4564 per share.
Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →
Acquisition (code M) of 125,000 shares at $1.55 per share.
Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code M
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →
Sale of 220,866 shares at $11.4997 per share.
Reporting Person Tak Paul Peter · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001873905-26-000002 · filed 2026-09-11 · View filing →
Sale of 7,000 shares at $12.00 per share.
Reporting Person Tyagarajan Seshu · Officer Title Chief Technology Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001923794-26-000004 · filed 2026-08-19 · View filing →